Michael J. Elliott
Equibles does not estimate personal net worth.
Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMVT alertsAbout Michael J. Elliott
The proxy statement of Immunovant, Inc. reports total compensation of $16,236,631 for Michael J. Elliott in fiscal 2020, including a base salary of $242,425. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.
Affiliation history
-
Immunovant, Inc. (IMVT)
Proxy statement
Current
Company network
Leadership on record at Immunovant, Inc.
- Eric Venker CEO
- Eric Venker, M.D. CEO, Board Member
- Eric Venker, M.D., Pharm.D. CEO
- Dr. Frank M. Torti Chairman
- Renee Barnett CFO
- Tiago Girao CFO
- Melanie Gloria COO
- Jay S. Stout CTO
- W. Bradford Middlekauff General Counsel
- Andrew Fromkin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Immunovant, Inc. (IMVT) | M.B.B.S., Ph.D., FRACP Former Chief Scientific Officer | $242,425 | $16,236,631 |
Recent activity
No call appearances or filed executive changes recorded yet.